Skip to main content

RHUMBLINE ADVISERS

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1115418 BOSTON, MA

Position in SNDX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,893,345
+$212,505 QoQ
Shares Held
132,358
+15.3% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 33% Shared 0% None 67%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. SNDX ranks #80 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SNDX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,893,345 132,358
2026-03-31 $2,680,840 114,762
2025-12-31 $2,495,966 118,799
2025-09-30 $2,025,727 131,669
2025-06-30 $1,205,575 128,732
2025-03-31 $1,484,150 120,810
2024-12-31 $1,499,795 113,449
2024-09-30 $2,203,335 114,459
2024-06-30 $2,448,921 119,285
2024-03-31 $2,594,057 108,994
2023-12-31 $2,059,800 95,317
2023-09-30 $1,437,029 98,969
2023-06-30 $2,057,377 98,298
2023-03-31 $1,918,836 90,854
2022-12-31 $2,050,455 80,568
2022-09-30 $1,893,275 78,788
2022-06-30 $1,371,157 71,266
2022-03-31 $1,012,193 58,239
2021-12-31 $1,241,666 56,723
2021-09-30 $1,098,805 57,499
2021-06-30 $951,200 55,399
2021-03-31 $710,332 31,768
2020-12-31 $727,092 32,693
2020-09-30 $453,515 30,726
2020-06-30 $500,086 33,744
2020-03-31 $257,509 23,474